RecallDepth
Class II Ongoing

Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14

This recall is currently active, issued January 7, 2026. It was issued by Novo Nordisk Inc.

Company
Novo Nordisk Inc
Recall Initiated
December 19, 2025
Posted
January 7, 2026
Recall Number
D-0245-2026
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Plainsboro, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Presence of Particulate Matter: Hair was found in a prefilled syringe

Distribution

Nationwide within the United States.

Lot / Code Info

Lot #: RZFYK06, RZFYA53; Exp Date 3/31/2027

More recalls by Novo Nordisk Inc

View all recalls by this company →

Other recent Class II Drug recalls